New research study at Augusta University for neuropathic pain in patients with spinal cord injuries

Hello everyone,

We are recruiting for a research study at Augusta University in Augusta, Georgia, to see how safe and effective a new drug (EC5026) is to treat patients with neuropathic pain related to a spinal cord injury.

OFFICIAL ANNOUNCEMENT: tinyurl.com/EC5026ClinicalTrial

CURRENTLY ENROLLING: RUM1MDI2Q2xpbmljYWxUcmlhbCB8IGdtYWlsICEgY29t

Study Description:
- Looking for adults with a T6-T12 spinal cord injury whose pain meets study requirements, and who have failed at least 2 classes of medications to treat the pain.
- Participants in this study may see improvement in their neuropathic pain.
- Taking part in this study will last about 2 months including the screening period, with daily study visits for the first 15 days (including two separate 3-day stays in the hospital for close monitoring), followed by 5 more visits over the next 4 weeks.
- Participants will receive a stipend for each study visit they complete, up to a maximum of $3,540.00.

For more information, please contact RUM1MDI2Q2xpbmljYWxUcmlhbCB8IGdtYWlsICEgY29t.